OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccination with the Inactivated Vaccine (Sinopharm BBIBP-CorV) Ensures Protection against SARS-CoV-2 Related Disease
Chao Wang, Linyi Chen, Qing‐Bin Lu, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 920-920
Open Access | Times Cited: 24

Showing 24 citing articles:

COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis
Angel A Justiz-Vaillant, Kimberly Roopnarine, Shaundell Solomon, et al.
Microorganisms (2025) Vol. 13, Iss. 1, pp. 135-135
Open Access

Self‐Reported Adverse Events Following COVID‐19 Vaccination Among Medical Sciences Students After a Symptomatology Training Program: A Cross‐Sectional Study
Taraneh Tavanaei Tamanaei, Mohammad Bagher Oghazian, Mehran Mojtabaee, et al.
Health Science Reports (2025) Vol. 8, Iss. 3
Open Access

COVID-19 Vaccines, Effectiveness, and Immune Responses
Haneen I. Abufares, Leen Oyoun Alsoud, Mohammad A. Y. Alqudah, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15415-15415
Open Access | Times Cited: 26

Perceived health literacy and COVID-19 vaccine acceptance among Chinese college students: A mediation analysis
Fangfang Jiang, Yang Zhao, Jianling Bai, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0273285-e0273285
Open Access | Times Cited: 19

COVID-19 Vaccines: An Updated Overview of Different Platforms
D.А. Kudlаy, Andrey Svistunov, Олег Викторович Сатышев
Bioengineering (2022) Vol. 9, Iss. 11, pp. 714-714
Open Access | Times Cited: 19

Ocular Implications of COVID-19 Infection and Vaccine-Related Adverse Events
Uday Pratap Singh Parmar, Pier Luigi Surico, Rohan Bir Singh, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 8, pp. 780-780
Open Access | Times Cited: 3

COVID-19 Vaccination and Alcohol Consumption: Justification of Risks
Pavel Solopov
Pathogens (2023) Vol. 12, Iss. 2, pp. 163-163
Open Access | Times Cited: 9

Assessing the Awareness and Attitude Towards COVID-19 Vaccination and Aids Factors among Jordanian People: A cross-sectional Study
Hindya Maqableh, Nisrein Makahleh, Sara Ajlouny, et al.
Jordan Journal of Pharmaceutical Sciences (2024) Vol. 17, Iss. 1, pp. 45-54
Open Access | Times Cited: 2

Analyzing hepatitis B transmission dynamics: Insights into clinical control and passive immunity strategies through mathematical modeling and simulation
James Khobocha Mirgichan, Cyrus Gitonga Ngari, Stephen Karanja, et al.
Journal of Mathematical Problems Equations and Statistics (2024) Vol. 5, Iss. 1, pp. 20-37
Open Access | Times Cited: 1

To be remembered: B cell memory response against SARS‐CoV‐2 and its variants in vaccinated and unvaccinated individuals
Nafees Ahmed, Atharv Athavale, Ankita Tripathi, et al.
Scandinavian Journal of Immunology (2023) Vol. 99, Iss. 2
Open Access | Times Cited: 4

The Equal Neutralizing Effectiveness of BNT162b2, ChAdOx1 nCoV-19, and Sputnik V Vaccines in the Palestinian Population
Alexia Damour, Muriel Faure, Nicolas Landrein, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 493-493
Open Access

Virus vaccine production using cell-based technology
Mahbuba Rahman
Elsevier eBooks (2024), pp. 295-340
Closed Access

Comparing the immunogenicity of COVID-19 infection and vaccination in pregnant women as measured by anti-S IgG
Zeinab Hemati, Saeideh Ameli, Bahram Nikkhoo, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access

Is there a Possible Association between Multiple Myeloma Relapse and Coronavirus Disease 2019 Vaccination? A Case Report
Nasrin Shirzad-Yazdi, Nasrin Namdari, A Noorani, et al.
Journal of Research in Pharmacy Practice (2024) Vol. 13, Iss. 1, pp. 27-32
Open Access

How well do different COVID-19 vaccines protect against different viral variants? A systematic review and meta-analysis
Hoang Thi Ngoc Anh, Aisling Byrne, Ha‐Linh Quach, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene (2024)
Open Access

Comparison of antibody responses of heterologous and homologous Covid-19 booster vaccination: an observational study
Nayab Batool Rizvi, Maryam Bibi, Majeed Rana, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access

Evaluation of BBIBP-CorV Sinopharm COVID-19 vaccine effectiveness in Sri Lanka: a test-negative case control study
Shamila De Silva, Dileepa Senajith Ediriweera, Wathsala Wimalasena, et al.
BMJ Open (2024) Vol. 14, Iss. 11, pp. e090341-e090341
Open Access

Characterization of cultured animal cells
Anjali Gupta, Sachin Kumar
Elsevier eBooks (2024), pp. 141-157
Closed Access

Altered T-cell receptor β repertoire in adults with SARS CoV-2 inactivated vaccine of BBIBP-CorV
Zhihui Quan, Aihong Qi, S. Ma, et al.
Molecular Immunology (2023) Vol. 162, pp. 54-63
Closed Access | Times Cited: 1

BBIBP-CorV (Sinopharm) vaccination- induced immunity is affected by age, gender and prior COVID-19 and activates responses to spike and other antigens
Zahra Hasan, Kiran Iqbal Masood, Shama Qaiser, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Closed Access | Times Cited: 2

Adverse Effects Post COVID-19 Vaccination and its Association with Age, Gender and Comorbid Disease in Basrah City Southern of Iraq
Zainab Najim Abdul-Nabi, Noor Kadhim Mohamed-Jawad, Noor Yousif Fareed, et al.
Current Drug Safety (2023) Vol. 19, Iss. 2, pp. 248-254
Closed Access

Therapeutic Modalities for Coronavirus SARS-CoV-2 (COVID-19)
Lydia Schmelling, Artur Manasyan, Gabriella Castranova, et al.
Advances in Hematology and Oncology Research (2022) Vol. 5, Iss. 1
Open Access

Page 1

Scroll to top